Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,334 | 60,241 | 137,658 | 60,660 | 143,428 |
| Marketable Securities | 154,484 | 197,572 | 16,000 | 931 | 6,381 |
| Receivables | 42,571 | 32,016 | 22,126 | 17,029 | 2,360 |
| Inventories | 910 | 6,703 | 6,640 | 8,444 | 8,272 |
| Other current assets | 46 | 18 | 204 | 424 | 293 |
| TOTAL | $314,875 | $329,497 | $208,132 | $109,163 | $184,586 |
| Non-Current Assets | |||||
| PPE Net | 114,264 | 129,597 | 133,004 | 135,270 | 137,094 |
| Intangibles | 0 | 14,475 | 14,977 | 15,443 | 0 |
| Other Non-Current Assets | 72,759 | 45,418 | 45,963 | 43,883 | 61,253 |
| TOTAL | $187,023 | $189,490 | $193,944 | $194,596 | $198,347 |
| Total Assets | $501,898 | $518,987 | $402,076 | $303,759 | $382,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,381 | 6,216 | 7,547 | 13,856 | 6,898 |
| Accrued Expenses | 46,838 | 43,602 | 35,705 | 27,889 | 40,580 |
| TOTAL | $61,754 | $57,134 | $50,644 | $49,205 | $54,944 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 939,732 | 985,284 | 921,270 | 845,056 | 816,135 |
| TOTAL | $939,718 | $985,263 | $921,251 | $845,036 | $816,118 |
| Total Liabilities | $1,001,472 | $1,042,397 | $971,895 | $894,241 | $871,062 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,028,111 | 984,965 | 945,255 | 882,620 | 853,442 |
| Common Shares | 101 | 98 | 91 | 85 | 85 |
| Retained earnings | -3,726,646 | -3,664,702 | -3,597,449 | -3,504,894 | -3,375,248 |
| Other shareholders' equity | 29,851 | 5,906 | 13,498 | 20,905 | 2,167 |
| TOTAL | $-499,574 | $-523,410 | $-569,819 | $-590,482 | $-488,129 |
| Total Liabilities And Equity | $501,898 | $518,987 | $402,076 | $303,759 | $382,933 |